+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases

Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases

Journal of Medicinal Chemistry 59(17): 7719-7737

Notch is a key player in various developmental processes during the embryonic stage as well as in regulating tissue homeostasis, cell differentiation, and stem cell maintenance in adult life. Activation of Notch signaling occurs following Notch receptor-ligand interaction and subsequent enzymatic proteolysis by the gamma-secretase complex, resulting in the cytoplasmic release of a Notch intracellular domain, which translocates to the nucleus to initiate the downstream transcriptional machinery. Notch activation and its aberrant signaling have been broadly linked to the pathogenesis of cancer and some chronic inflammatory diseases resulting in pathologic fibrotic processes. This review focuses on the molecular basis of Notch-induced signaling and its interaction with other pathways to identify therapeutic targets. We also highlight current efforts to pharmacologically intervene in Notch signaling and discuss promising ongoing experimental and clinical studies.

(PDF emailed within 0-6 h: $19.90)

Accession: 058427972

Download citation: RISBibTeXText

PMID: 27045975

DOI: 10.1021/acs.jmedchem.5b01516

Related references

Formyl peptide receptor modulators: a patent review and potential applications for inflammatory diseases (2012-2015). Expert Opinion on Therapeutic Patents (): 1-18, 2016

Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: Potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Neurochemical Research 26(4): 383-394, August, 2001

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opinion on Investigational Drugs 20(7): 897-915, 2012

Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies. Frontiers in Immunology 3: 256-256, 2012

Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clinical and Experimental Immunology 157(1): 27-34, 2009

Histamine and TNF-alpha production by substance P in mast cell is inhibited by SP-antagonists Evidences for a mechanism and potential therapy in neuro-inflammatory diseases. Society for Neuroscience Abstracts 24(1-2): 2001, 1998

Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer. Current Pharmaceutical Design 22(41): 6209-6233, 2016

Role of complement C5a in mechanical inflammatory hypernociceptio: potential use of C5a receptor antagonists to control inflammatory pain. British Journal of Pharmacology 153(5): 1043-1053, 2008

Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases. Annales de Dermatologie et de Venereologie 139(6-7): 459-467, 2012

Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators. European Journal of Medicinal Chemistry 70: 811-830, 2014

CD33-related siglecs as potential modulators of inflammatory responses. Annals of the New York Academy of Sciences 1253: 102-111, 2012

RORγt Modulators Are Potentially Useful for the Treatment of the Immune-Mediated Inflammatory Diseases. Acs Medicinal Chemistry Letters 5(8): 844-845, 2014

Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. Journal of Immunology Research 2015: 832057-832057, 2016

Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World Journal of Gastroenterology 21(4): 1081-1090, 2015